SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-18 |
| Reported value | $427,498,391 |
| Positions | 38 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SPDR S&P 500 ETF TR | SPY | TR UNIT | $238,672,000 | 350,000 |
| INVESCO QQQ TR | QQQ | UNIT SER 1 | $30,715,500 | 50,000 |
| ANGIODYNAMICS INC | ANGO | COM | $21,997,218 | 1,713,789 |
| AURINIA PHARMACEUTICALS INC | AUPH | COM | $19,536,294 | 1,224,846 |
| AVADEL PHARMACEUTICALS PLC | AVDL | COM SHS | $18,951,070 | 879,400 |
| AVADEL PHARMACEUTICALS PLC | AVDL | COM SHS | $15,975,942 | 741,343 |
| OMEROS CORP | OMER | COM | $15,554,281 | 905,635 |
| NEUROPACE INC | NPCE | COM | $9,749,866 | 631,468 |
| MEDIWOUND LTD | MDWD | SHS NEW | $6,225,377 | 337,236 |
| AXOGEN INC | AXGN | COM | $5,498,640 | 168,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.